Skip to main content
DONGWHA PHARM.CO.,LTD logo

DONGWHA PHARM.CO.,LTD — Investor Relations & Filings

Ticker · 000020 ISIN · KR7000020008 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2023-03-08 Proxy Solicitation & In…
Country KR South Korea
Listing KO 000020

About DONGWHA PHARM.CO.,LTD

https://www.dong-wha.co.kr

Dongwha Pharm is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a diverse range of healthcare products. Its portfolio includes ethical (prescription) pharmaceuticals, over-the-counter (OTC) drugs, medical devices, quasi-drugs, health functional foods, cosmetics, and beverages. The company's research and development efforts focus on various therapeutic areas, including alimentary and cardiovascular systems. Dongwha Pharm actively pursues innovation through its drug pipeline, clinical trials, and strategic investments in emerging fields like digital therapeutics.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Dong-A Pharmaceutical. It contains the agenda for the Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed proxy information, such as candidate profiles, voting procedures (electronic voting), and management's discussion of business. This document is a standard proxy statement sent to shareholders to solicit votes for the upcoming meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea for companies to solicit proxies from shareholders ahead of an Annual General Meeting (AGM). It contains information about the meeting date, agenda items (such as approval of financial statements, election of directors), and instructions for electronic voting. While it contains financial statements, these are provided as reference material for the shareholders' meeting, not as a standalone annual report. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2023-03-08 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure of 'Changes in Sales or Profit/Loss Structure of 30% or more'. It provides updated financial figures (Net Income, Assets, Equity) due to tax adjustments. Since this is a specific regulatory disclosure regarding financial performance updates that does not fit into the standard categories of full Annual Reports or Earnings Releases, it is classified as a Regulatory Filing (RNS). FY 2022
2023-03-06 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information Classification · 1% confidence The document is a regulatory disclosure from Dongwha Pharm regarding its 'Compliance Program' (CP) operational status, performance, and future plans. It details internal governance, training, and monitoring activities. Since this is a specific regulatory disclosure regarding corporate governance and compliance practices that does not fit into financial reporting or other specific categories, it is classified as a Regulatory Filing (RNS).
2023-02-20 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Dongwha Pharm regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the upcoming general meeting of shareholders to approve the dividend. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2023-02-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. This type of filing is a regulatory requirement for shareholders who cross specific ownership thresholds (typically 5% or more) in a listed company. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ).
2023-02-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.